Skip to main content

Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years

The data confirms the rise in demand for GLP-1s, which have fueled a frenzy among Americans and on Wall Street for their ability to cause weight loss.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.